Shandong Boan Biotechnology Company., Limited. Class H (HK:6955) has released an update.
Shandong Boan Biotechnology Co., Ltd. successfully completed the placement of new shares, generating HK$250.68 million in net proceeds. This strategic move, which involved the sale of approximately 4.97% of its enlarged shares to at least six independent placees, aims to fund the company’s future endeavors. The raised capital will be allocated to research and development, the commercialization of its products, and bolstering the company’s working capital and general corporate purposes.
For further insights into HK:6955 stock, check out TipRanks’ Stock Analysis page.
